A 62-year-old man with hypertension, hyperlipidemia, type 2 diabetes, and chronic kidney disease presents with symptoms consistent with acute decompensated heart failure. He has had multiple hospital admissions over the past year. During a previous hospitalization, he underwent nuclear cardiac stress testing which was negative for ischemia or infarction. Cardiac catheterization performed at that time…
The FDA has granted Fast Track designation to empagliflozin for the reduction of the risk of cardiovascular death and hospitalization in patients with chronic heart failure.
Patients with nonspecific intraventricular conduction delay and QRS duration <150 ms or
right bundle branch block may not benefit from cardiac resynchronization therapy with defibrillator, compared with implantable cardioverter-defibrillator therapy alone.
Revascor is a cell therapy that consists of 150 million allogeneic mesenchymal precursor cells and is delivered as a single intra-myocardial injection.
Patients with heart failure, severe pulmonary hypertension, and a preserved ejection fraction of ≥50% had a worse prognosis when compared with other patients with heart failure and severe pulmonary hypertension.
In a large, multicenter cohort of patients with heart failure reduced ejection fraction, changes in medications were associated with rapid improvements in patients’ health status, as measured by the Kansas City Cardiomyopathy Questionnaire.
For left ventricular assist device recipients, those on phosphodiesterase-5 inhibitors have a higher incidence of severe early right heart failure.
The American Heart Association and Heart Failure Society released a joint scientific statement summarizing the effects of type 2 diabetes management on heart failure outcomes.
The FDA has approved the use of Corlanor for the treatment of stable symptomatic heart failure due to dilated cardiomyopathy in pediatric patients aged 6 months and older.
Viewing mild pulmonary hypertension as a high-risk clinical parameter in heart failure with preserved ejection fraction could pave a way forward for early intervention.
